Filing Details
- Accession Number:
- 0001209191-20-059268
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-11-18 19:48:57
- Reporting Period:
- 2020-11-17
- Accepted Time:
- 2020-11-18 19:48:57
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1674930 | Fulgent Genetics Inc. | FLGT | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1183863 | C John Bolger | C/O Fulgent Genetics, Inc. 4978 Santa Anita Ave. Temple City CA 91780 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-11-17 | 2,631 | $0.38 | 4,644 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-11-17 | 4,269 | $44.24 | 375 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Options (Right to Buy) | Disposition | 2020-11-17 | 2,631 | $0.00 | 2,631 | $0.38 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2026-04-12 | No | 4 | M | Direct |
Footnotes
- The shares were sold in multiple transactions at prices ranging from $44.16 to $44.3784, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
- The shares subject to the option vested over a period of four years, with 1/4th of such shares vesting 12 months after April 13, 2016, and 1/16th of such shares vesting every three months over the remaining 36 months, subject to the reporting person's continued service for the Issuer on each vesting date.